Ortho-Clinical Diagnostics posted sales of $1.89bn last year, which accounted for 2.6 per cent of J&J’s total revenues. The company medical screening, diagnosis and monitoring equipment in 130 countries.
Carlyle agreed a deal to buy the unit for what at the time was reported to be $4.15bn in January.
Bain Capital, BC Partners and the pairing of Leonard Green & Partners and CVC Capital were previously said to be interested in buying the business.
Carlyle said equity for the deal came from Carlyle Partners VI, the $13bn US buyout fund it closed in November 2013.
Copyright © 2014 AltAssets